EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allicin‒Decorated FeO 1‐x OH Nanocatalytic Medicine for Fe 2+ /Fe 3+ Cycling‒Promoted Efficient and Sustained Tumor Regression

Zhongming Jie, Bingyan Xiong iD, Jianlin Shi iD

Advanced Science · 2024

DOI: 10.1002/advs.202402801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhongming Jie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai, 20007…. Hauptthemen laut MEDLINE: Disulfides, Sulfinic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research Program of Frontier Sciences, Chinese Academy of Sciences, Basic Research Program of Shanghai Municipal Government, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the tumor treatment by Fenton reaction‒based nanocatalytic medicines, the gradual consumption of Fe(II) ions greatly reduces the production of hydroxyl radicals, one of the most active reactive oxygen species (ROS), leading to much deteriorated therapeutic efficacy. Meanwhile, the ROS consumption caused by the highly expressed reduced glutathione (GSH) in the tumor microenvironment further prevents tumor apoptosis. Therefore, using the highly expressed GSH in tumor tissue to promote the Fe(III) reduction to Fe(II) can not only weaken the resistance of tumor to ROS attack, but also generate enough Fe(II) to accelerate the Fenton reaction. In view of this, an allicin‒modified FeO 1‐x OH nanocatalyst possessing varied valence states (II, III) has been designed and synthesized. The coexistence of Fe(II)/Fe(III) enables the simultaneous occurrence of Fenton reaction and GSH oxidation, and the Fe(III) reduction by GSH oxidation results in the promoted cyclic conversion of Fe ions in tumor and positive catalytic therapeutic effects. Moreover, allicin capable of regulating cell cycle and suppressing tumor growth is loaded on FeO 1‐x OH nanosheets to activate immune response against tumors and inhibit tumor recurrence, finally achieving the tumor regression efficiently and sustainably. This therapeutic strategy provides an innovative approach to formulate efficient antitumor nanomedicine for enhanced tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DisulfidesSulfinic AcidsAnimalsMiceReactive Oxygen SpeciesCatalysisIronDisease Models, AnimalCell Line, TumorHumansNeoplasmsTumor MicroenvironmentNanomedicineGlutathione

Stichwörter der Autor:innen

Fe(II, III) cyclingFenton reactionGSH oxidationallicintumor therapy

Substanzen

allicinDisulfidesSulfinic AcidsReactive Oxygen SpeciesIronGlutathione

Autor:innen und Institutionen

  • Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.
  • School of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
  • Shanghai Institute of Ceramics, Chinese Academy of Sciences, Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012), Shanghai, 200050, P. R. Chin…
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

ORCID-Profile: Bingyan Xiong, Jianlin Shi

Förderung

  • Key Research Program of Frontier Sciences, Chinese Academy of Sciences
  • Basic Research Program of Shanghai Municipal Government
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Jie, Z., Xiong, B., & Shi, J. (2024). Allicin‒Decorated FeO 1‐x OH Nanocatalytic Medicine for Fe 2+ /Fe 3+ Cycling‒Promoted Efficient and Sustained Tumor Regression. Advanced Science. https://doi.org/10.1002/advs.202402801

Vancouver

Jie Z, Xiong B, Shi J. Allicin‒Decorated FeO 1‐x OH Nanocatalytic Medicine for Fe 2+ /Fe 3+ Cycling‒Promoted Efficient and Sustained Tumor Regression. Advanced Science. 2024. doi:10.1002/advs.202402801

BibTeX
@article{Jie2024,
  author = {Jie, Zhongming and Xiong, Bingyan and Shi, Jianlin},
  title = {Allicin‒Decorated FeO 1‐x OH Nanocatalytic Medicine for Fe 2+ /Fe 3+ Cycling‒Promoted Efficient and Sustained Tumor Regression},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202402801}
}
Kostenlos starten →